Comparative study of behavioural problems among epileptic children treated with phenobarbital with epileptic children treated with phenytoin
Journal Title: Zahedan Journal of Research in Medical Sciences - Year 2011, Vol 12, Issue 5
Abstract
Background: Phenobarbital is recommended by WHO as the first line drug for the treatment of partial and generalized tonic clonic epilepsies in developing countries, however several clinical trials have recorded higher frequencies of behavioural problems associated with Phenobarbital than with other drugs or no treatment. We compared the frequency of behavioural problems among epileptic children treated with phenobarbital with epileptic children treated with phenytoin. Materials and Method: We conducted a case-control study to comparing of epileptic children treatment with neurological with epileptic children treated with phenytoin. Between November 2006 to March 2007, 74 children referred from child neurologic clinic who treated with phenobarbital or phenytoin for more than 2 months in Zahedan, assessed consecutively by the Rutters behaviour scale for children aged 6 years and older and by the preschool behaviour questionnaire for those 2-5 years. Results: The mean scores on the behaviour scales did not differ significantly between the phenobarbital and phenytoin groups in children aged 6 years and older. Irretability, attention deficit, disobedience and lack of energy in phenobarbital group more than phenytoin group in 2-5 years old children. Conclusion: Several clinical trials have recorded higher frequencies (20-60%) of behavioural problems associated with phenobarbital than with other drugs but in our study evidence supports the acceptability of phenobarbital for epileptic children in developing countries. [ZJRMS, 12(5):60-64] Keywords: Phenobarbital, phenytoin, children, epilepsy, treatment, adverse effects
Authors and Affiliations
Mohsen Javadzadeh , Noormohammad Bakhshani , Aida Afghani
Keywords
Related Articles
- EP ID EP86204
- DOI -
- Views 136
- Downloads 0
Analysis of HLA-DRB1*1501 in Multiple Sclerosis Patients in Khuzestan Province, Iran
Background: Multiple sclerosis (MS) is a demyelinating, autoimmune and neurodegenerative disease of the central nervous system (CNS). The pathogenesis of this disease is still unknown, although there are evidences of env...
Comparison of patterns of substance abuse disorders in urban and rural population
Background: Studies of the prevalence of substance abuse in rural and urban population in different countries revealed variable results regarding to the study method, study population, age group and measuring tools. The...
Prevalence of asthma symptoms and allergic diseases with ISSAC method in children, Shiraz 2009
Background: Asthma is the most important chronic disease in children and the most common cause of school absenteeism. Its prevalence has been raised due to increased environmental and industrial. This study were designed...
Determination of Frequency of Bacterial Agent Causing Ventilator Associated Pneumonia in the Patients Hospitalized in the Intensive Care Unit of Tonkabon Shahid Rajaei Hospital by PCR Sequencing
Background: Ventilator associated pneumonia (VAP) is the most prevalent hospitalized infection in the intensive care unit (ICU) causing increase of the therapeutic costs and mortality. Objectives: The purpose of this st...
Antibacterial Activity of Silver Nanoparticles Synthesized by Using Extracts of Hedera helix
Background: Silver nanoparticles (AgNPs) are one of the most widely applicable particles whose application is increasing in Nano world daily. Silver nanoparticles have expressed significant advances owing to wide range o...